Exhaled and nasal NO levels in patients with primary cilliary dyskinesia (PCD)

J. Pawlik, W. Tomalak, W. Myszkal, J. Radlinski (Rabka, Poland)

Source: Annual Congress 2007 - Lung function and therapy in obstructive lung diseases
Session: Lung function and therapy in obstructive lung diseases
Session type: Electronic Poster Discussion
Number: 4370

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Pawlik, W. Tomalak, W. Myszkal, J. Radlinski (Rabka, Poland). Exhaled and nasal NO levels in patients with primary cilliary dyskinesia (PCD). Eur Respir J 2007; 30: Suppl. 51, 4370

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
New portable nasal nitric oxide (nNO) analyser differentiates primary ciliary dyskinesia (PCD) from healthy individuals.
Source: International Congress 2017 – Primary ciliary dyskinesia and air pollution
Year: 2017


Markers of airway inflammation in primary ciliary dyskinesia studied using exhaled breath condensate
Source: Eur Respir J 2005; 26: Suppl. 49, 623s
Year: 2005

Eicosanoids in exhaled breath condensate of children with primary ciliary dyskinesia
Source: Eur Respir J 2001; 18: Suppl. 33, 180s
Year: 2001

Nasal nitric oxide measurements for the screening of primary ciliary dyskinesia
Source: Eur Respir J 2003; 21: 43-47
Year: 2003



Nasal nitric oxide is low early in life: case study of two infants with primary ciliary dyskinesia
Source: Eur Respir J 2004; 24 : 881-883
Year: 2004



Upper and lower airway nitric oxide levels in primary ciliary dyskinesia
Source: Annual Congress 2012 - New understanding of childhood lung disease through physiological measurement
Year: 2012


Nitric oxide metabolites in exhaled breath condensate of children with primary ciliary dyskinesia
Source: Eur Respir J 2001; 18: Suppl. 33, 180s
Year: 2001

Nasal cavity inflammation in patients with primary ciliary dyskinesia (PCD) is associated with bacterial infection
Source: International Congress 2017 – Paediatric respiratory infections and immunity
Year: 2017



Correlation between cough frequency and airway inflammation in children with primary ciliary dyskinesia (PCD)
Source: Annual Congress 2004 - Chronic respiratory illness in childhood
Year: 2004


Nasal nitric oxide measurement in 39 children consecutively referred for primary ciliary dyskinesia work up
Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome
Year: 2007


Nitric oxide biosynthesis by primary ciliary dyskinesia respiratory epithelial cells is similar to non-PCD patients
Source: Annual Congress 2012 - Cell culture and animal models of lung disease
Year: 2012


Exhaled NO (FeNO) levels in patients with exacerbation of COPD and/or bronchiectasis
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018


Exhaled NO levels in patients with chronic cough in Japan
Source: Eur Respir J 2006; 28: Suppl. 50, 671s
Year: 2006

Nasal nitric oxide (nNO) in paediatric primary ciliary dyskinesia (PCD) and in healthy children - On the lookout for optimal cut-off and reference range
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016


Choice of nasal nitric oxide technique as first-line test for primary ciliary dyskinesia
Source: Eur Respir J 2011; 37: 559-565
Year: 2011



Ciliary dyskinesias: primary ciliary dyskinesia in adults
Source: Eur Respir Mon 2011; 52: 130-149
Year: 2011


Lack of nasal nitric oxide increase by humming in primary ciliary dyskinesia
Source: Annual Congress 2003 - Advances in paediatric respiratory physiology
Year: 2003


Relevance of nasal nitric oxide measurements using tidal breathing method for screening primary ciliary dyskinesia in young children
Source: Virtual Congress 2020 – Respiratory physiology and sleep: new approaches to diagnosis and treatment
Year: 2020

Alveolar but not airway fractional exhaled nitric oxide concentration (FENO) is decreased in obstructive sleep apnea syndrome (OSAS)
Source: Eur Respir J 2003; 22: Suppl. 45, 467s
Year: 2003

The influence of short-term therapy of continous positive airway pressure (CPAP) on exhaled nitric oxide concentration (FENO) in patients with obstructive sleep apnea (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 357s
Year: 2005